Efficacy, safety, and tolerability of atogepant for the acute treatment of migraine: Results from the ECLIPSE trial

Authors
Category Primary study
Conference19th European Headache Congress, EHC
Year 2026
This article has no abstract
Epistemonikos ID: d7d1bbfb580b073d00db4a409f7483138d65d4ba
First added on: Aug 15, 2026